Henry Y Dong

Summary

Affiliation: IMPATH Inc
Country: USA

Publications

  1. ncbi B-cell lymphomas with coexpression of CD5 and CD10
    Henry Y Dong
    IMPATH Inc, 521W 57th St, 6th Floor, New York, NY 10019, USA
    Am J Clin Pathol 119:218-30. 2003
  2. ncbi B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in merkel cell carcinoma and small cell carcinomas
    Henry Y Dong
    Genzyme Genetics IMPATH, New York, NY 10019, USA
    Am J Surg Pathol 29:687-92. 2005
  3. ncbi Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics
    Henry Y Dong
    Genzyme Genetics, 521 W 57th St, New York, NY 10019, USA
    Am J Clin Pathol 131:586-95. 2009
  4. ncbi Detection of the t(11;18) API2/MALT1 translocation associated with gastric MALT lymphoma in routine formalin-fixed, paraffin-embedded small endoscopic biopsy specimens by robust real-time RT-PCR
    Weisu Zhang
    Genzyme Genetics, New York, NY, USA
    Am J Clin Pathol 126:931-40. 2006
  5. ncbi Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities
    Henry Y Dong
    Genzyme Genetics, New York, NY 10019, USA
    Am J Clin Pathol 135:76-84. 2011
  6. ncbi CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis
    Wojciech Gorczyca
    IMPATH Inc, New York, NY 10019, USA
    Int J Oncol 22:319-24. 2003
  7. ncbi CD5- mantle cell lymphoma
    Zach Liu
    IMPATH, New York, NY 10019, USA
    Am J Clin Pathol 118:216-24. 2002
  8. ncbi Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation
    Sarah E Gibson
    Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Clin Pathol 126:916-24. 2006
  9. ncbi Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)
    Scott J Rodig
    Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Cancer Res 12:7174-9. 2006
  10. ncbi CD148 and CD27 are expressed in B cell lymphomas derived from both memory and naïve B cells
    Henry Y Dong
    Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA
    Leuk Lymphoma 43:1855-8. 2002

Collaborators

Detail Information

Publications12

  1. ncbi B-cell lymphomas with coexpression of CD5 and CD10
    Henry Y Dong
    IMPATH Inc, 521W 57th St, 6th Floor, New York, NY 10019, USA
    Am J Clin Pathol 119:218-30. 2003
    ..Investigation of bcl-1, bcl-6, and CD43 and morphologic evaluation may resolve the potential confusion in diagnosis and lead to the recognition of the correct lymphoma subtype...
  2. ncbi B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in merkel cell carcinoma and small cell carcinomas
    Henry Y Dong
    Genzyme Genetics IMPATH, New York, NY 10019, USA
    Am J Surg Pathol 29:687-92. 2005
    ..We conclude that expression of PAX-5 is not confined to the B cell lineage and is frequently associated with neuroendocrine carcinomas...
  3. ncbi Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics
    Henry Y Dong
    Genzyme Genetics, 521 W 57th St, New York, NY 10019, USA
    Am J Clin Pathol 131:586-95. 2009
    ..We suggest categorizing CD103+ B-lymphoproliferative disorders into 2 groups. While HCL coexpresses CD25 and annexin-A1, diseases lacking CD25 and annexin-A1 behave clinically differently and can be separated from HCL on diagnosis...
  4. ncbi Detection of the t(11;18) API2/MALT1 translocation associated with gastric MALT lymphoma in routine formalin-fixed, paraffin-embedded small endoscopic biopsy specimens by robust real-time RT-PCR
    Weisu Zhang
    Genzyme Genetics, New York, NY, USA
    Am J Clin Pathol 126:931-40. 2006
    ..Our findings suggest that real-time RT-PCR for t(11;18) may be a valuable tool with much relevance in the current clinical management scheme...
  5. ncbi Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities
    Henry Y Dong
    Genzyme Genetics, New York, NY 10019, USA
    Am J Clin Pathol 135:76-84. 2011
    ..FCM effectively provides independent detection of APL during diagnostic workup and harmonizes with the subsequent molecular cytogenetic diagnosis...
  6. ncbi CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis
    Wojciech Gorczyca
    IMPATH Inc, New York, NY 10019, USA
    Int J Oncol 22:319-24. 2003
    ..It is incumbent upon the pathologist to distinguish between these two clinicopathologic entities, since treatment options and clinical outcomes differ...
  7. ncbi CD5- mantle cell lymphoma
    Zach Liu
    IMPATH, New York, NY 10019, USA
    Am J Clin Pathol 118:216-24. 2002
    ..These data show that MCL may lack CD5 expression. Evaluation of bcl-1 expression by immunohistochemical analysis or molecular genetics may be indicated if MCL is suspected clinically or morphologically despite a lack of CD5 expression...
  8. ncbi Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation
    Sarah E Gibson
    Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Clin Pathol 126:916-24. 2006
    ..Although OCT-2 and BOB.1 were not associated with PAX5 expression, we report expression of OCT-2 in AML with myelomonocytic/monocytic maturation and BOB.1 in normal hematopoietic elements...
  9. ncbi Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)
    Scott J Rodig
    Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Cancer Res 12:7174-9. 2006
    ..The utility of CAMPATH in the treatment of other hematologic neoplasms has been explored; however, a comprehensive survey of CD52 expression among a broad spectrum of WHO-defined tumor types has not been completed...
  10. ncbi CD148 and CD27 are expressed in B cell lymphomas derived from both memory and naïve B cells
    Henry Y Dong
    Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA
    Leuk Lymphoma 43:1855-8. 2002
    ..Our findings demonstrate that CD148 and CD27 are expressed in a wide range of B cell non-Hodgkin's lymphomas, and, therefore, do not serve to distinguish between neoplastic cells of naïve and memory B cell derivation...
  11. ncbi KSHV- and EBV-associated germinotropic lymphoproliferative disorder
    Ming Qing Du
    Department of Histopathology, Royal Free and University College Medical School, University College London, Rockefeller Building, University Street, London WC1E 6JJ, UK
    Blood 100:3415-8. 2002
    ..We propose calling this distinctive entity "KSHV-associated germinotropic lymphoproliferative disorder."..
  12. ncbi Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm
    Henry Y Dong
    Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Am J Surg Pathol 29:1633-41. 2005
    ..We conclude that most plasmacytic tumors in HIV-positive individuals are extramedullary, clinically aggressive EBV(+) tumors identical to plasmablastic lymphoma that does not have the clinical features of plasma cell myeloma...